Stock comparison
Genmab A/S
Intuitive Surgical
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
GMAB
Genmab A/S
Market cap
$16.5B
Sector
Healthcare
ISRG
Intuitive Surgical
Market cap
$155.16B
Sector
Healthcare
Overall winner
Intuitive Surgical ISRG
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | GMAB | ISRG | Winner |
|---|---|---|---|
| Warren Buffett | 65C | 64C | GMAB |
| Benjamin Graham | 64C | 89A | ISRG |
| Philip Fisher | 48D | 79B | ISRG |
| Peter Lynch | 25F | 76B | ISRG |
| Joel Greenblatt | 76B | 61C | GMAB |
| Charlie Munger | 68C | 69B | ISRG |
| Terry Smith | 71C | 66B | GMAB |
Side-by-side metrics
| Metric | GMAB | ISRG |
|---|---|---|
| Market cap | $16.5B | $155.16B |
| P/E (TTM) | 6.2x | 50.2x |
| EV/EBIT | 12.0x | 49.9x |
| ROIC (TTM) | 43.78% | 16.49% |
| Gross margin | 93.88% | 66.29% |
| Net margin | 18.23% | 28.15% |
| Revenue CAGR 5y | -18.45% | 15.22% |
| EPS CAGR 5y | -23.48% | 13.68% |
| Debt / Equity | 0.1x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
GMAB leads on
- P/E (TTM)6.2xvs 50.2x+88%
- EV/EBIT12.0xvs 49.9x+76%
- ROIC (TTM)43.78%vs 16.49%+62%
- Gross margin93.88%vs 66.29%+29%
ISRG leads on
- Revenue CAGR 5y15.22%vs -18.45%+183%
- EPS CAGR 5y13.68%vs -23.48%+158%
- Debt / Equity-vs 0.1x+100%
- Market cap$155.16Bvs $16.5B+89%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.